4 months ago
MRK
AnalystsEvan David SeigermanEvan David Seigerman's Stock Forecasts
AnalystsEvan David Seigerman
Sectors:
Industries:
Analyst Ranking
Top 21%
#1104 out of 5254 analysts
Average Return
+8.74%
Win Rate
55%28 out of 51
Risk vs Reward
Poor
Good
Evan David Seigerman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Candel Therapeutics IncCADL | +568.75% | $1.60 | $10.70 | 2023-05-15 - 2024-05-14 | Buy |
Morphic Holding IncMORF | +147.53% | $22.49 | $55.67 | 2023-09-28 - 2024-07-09 | Buy |
Eli Lilly & CoLLY | +81.93% | $306.82 | $558.19 | 2022-09-06 - 2023-09-05 | Buy |
Merus NvMRUS | +63.22% | $55.14 | $90.00 | 2025-05-23 - 2025-12-29 | Buy |
Regeneron Pharmaceuticals IncREGN | +52.92% | $490.81 | $750.57 | 2025-06-02 - 2026-04-17 | Buy |
Evan David Seigerman Analyst Color
Get additional color on Evan David Seigerman's coverage of popular stocks
5 months ago
NVO
6 months ago
NVO
a year ago
NVO
a year ago
MRK
a year ago
NVO
3 years ago
PFE
Evan David Seigerman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Disc Medicine IncIRON | 2 | Buy | $100.00 | +39.33% | Maintains | 2 months ago |
Merck & Co IncMRK | 5 | Buy | $130.00 | +9.18% | Upgrades | 4 months ago |
Regeneron Pharmaceuticals IncREGN | 9 | Buy | $850.00 | +13.25% | Maintains | 5 months ago |
Amgen IncAMGN | 5 | Buy | $372.00 | +4.70% | Maintains | 5 months ago |
Novo Nordisk A SNVO | 8 | Hold | $46.00 | +13.52% | Maintains | 5 months ago |
Replimune Group IncREPL | 5 | Hold | $11.00 | +406.91% | Upgrades | 6 months ago |
Abbvie IncABBV | 8 | Buy | $240.00 | +15.17% | Maintains | 7 months ago |
Neurogene IncNGNE | 2 | Buy | $26.00 | -6.64% | Maintains | 10 months ago |
Merus NvMRUS | 1 | Buy | $110.00 | +22.22% | Maintains | a year ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $28.00 | +26.30% | Maintains | a year ago |
Arvinas IncARVN | 1 | Buy | $10.00 | -9.09% | Maintains | a year ago |
Morphic Holding IncMORF | 3 | Hold | $57.00 | N/A | Downgrades | 2 years ago |
Structure Therapeutics IncGPCR | 2 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Pfizer IncPFE | 4 | Buy | $36.00 | N/A | Reiterates | 2 years ago |
Mirati Therapeutics IncMRTX | 4 | Hold | $72.00 | N/A | Maintains | 3 years ago |
Candel Therapeutics IncCADL | 1 | Buy | $3.00 | N/A | Maintains | 3 years ago |
Eli Lilly & CoLLY | 1 | Buy | $396.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.